1 Min Read
The headline fight in FY2025 pharma happened at the very top of the leaderboard, where Keytruda held the No. 1 brand slot even as Lilly’s tirzepatide and Novo’s semaglutide passed it at the molecule level. We covered that reshuffle in a separate analysis. Look past Keytruda, Mounjaro and Ozempic and the FY2025 table shows an… The post Pharma 50: The 50 best-selling drugs of FY2025 appeared first on Drug Discovery and Development.
Work & Theory on April 11, 2026
Uncategorized